Sm. Demos et al., IN-VITRO TARGETING OF ANTIBODY-CONJUGATED ECHOGENIC LIPOSOMES FOR SITE-SPECIFIC ULTRASONIC IMAGE-ENHANCEMENT, Journal of pharmaceutical sciences, 86(2), 1997, pp. 167-171
Tissue-specific ultrasonic enhancement can be used for the detection a
nd characterization of atherosclerosis. We have previously demonstrate
d the generation of inherently echogenic (acoustically reflective) lip
osomes solely by varying lipid composition and controlling the method
of production. In this study, echogenic liposomes composed of phosphat
idylcholine (PC), 4-(p-maleimidophenyl) butyryl phosphatidylethanolami
ne (MPB-PE), phosphatidylglycerol (PG), and cholesterol were conjugate
d to human gamma globulin to determine the effect of antibody conjugat
ion on liposomal acoustic reflectivity. The liposomes remained highly
echogenic following antibody conjugation. Echogenic liposomes were als
o conjugated to rabbit antihuman fibrinogen to study their ability to
target fibrin. Antibody-conjugated liposomes were targeted to fibrin-c
oated filter paper and slides, thrombi made in vitro, and segments of
atheroma in an animal model of atherosclerosis. Liposomes were detecte
d by scanning electron microscopy, radiolabeling, and imaging with int
ravascular ultrasound. Electron microscopy revealed attachment of anti
body-conjugated liposomes to fibrin on slides and to the fibrous plaqu
es of the arterial segments, whereas unconjugated liposomes did not at
tach. Similarly, conjugated liposomes did not attach to normal arterie
s, indicating their binding to the arterial segment is directed toward
s a component of the fibrous plaque. Ultrasound imaging of the thrombi
demonstrated surface attachment of the acoustic conjugated liposomes.
I-125-Labeled liposomes conjugated to rabbit anti-human were targeted
to fibrin-coated paper. Counting specifically bound radioactivity sho
wed that >84% of applied liposomes remained attached to the fibrin aft
er washing with saline. These results demonstrate the potential of aco
ustically reflective liposomes for site-specific targeting and acousti
c enhancement.